CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
301MO Genomic HLA as a predictive biomarker for survival among non-small cell lung cancer patient treated with single agent immunotherapy
Authors
A. Abed
S. Bowyer
+8Â more
L. Calapre
A. Chopra
S. Correia
E. Gray
M. Khattak
J. Lo
M. Millward
M. Watson
Publication date
1 January 2020
Publisher
Elsevier Inc.
Abstract
We aimed to assess the role of genomic HLA-I/II homozygosity in the overall survival benefit in patients with unresectable locally advanced, metastatic non-small lung cancer treated by single agent PD1/PDL1 inhibitors..
Similar works
Full text
Available Versions
Research Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:researchrepository.murdoch...
Last time updated on 08/04/2021